Počet záznamů: 1  

Oxylipin profiling for clinical research: Current status and future perspectives

  1. 1.
    0587350 - FGÚ 2025 RIV GB eng J - Článek v odborném periodiku
    Parchem, K. - Letsiou, S. - Petan, T. - Oskolkova, O. - Medina, I. - Kuda, Ondřej - O'Donnell, V. B. - Nicolaou, A. - Fedorova, M. - Bochkov, V. - Gladine, C.
    Oxylipin profiling for clinical research: Current status and future perspectives.
    Progress in Lipid Research. Roč. 95, July (2024), č. článku 101276. ISSN 0163-7827. E-ISSN 1873-2194
    Grant CEP: GA MŠMT(CZ) LX22NPO5104
    GRANT EU: European Commission(XE) CA19105 - EpiLipidNET
    Grant ostatní: AV ČR(CZ) LQ200111901
    Program: Prémie Lumina quaeruntur
    Institucionální podpora: RVO:67985823
    Klíčová slova: lipid mediators * epilipids * lipidomics * oxylipins * eicosanoids * clinical translation
    Obor OECD: Analytical chemistry
    Impakt faktor: 13.6, rok: 2022
    Způsob publikování: Open access
    https://doi.org/10.1016/j.plipres.2024.101276

    Oxylipins are potent lipid mediators with increasing interest in clinical research. They are usually measured in systemic circulation and can provide a wealth of information regarding key biological processes such as inflammation, vascular tone, or blood coagulation. Although procedures still require harmonization to generate comparable oxylipin datasets, performing comprehensive profiling of circulating oxylipins in large studies is feasible and no longer restricted by technical barriers. However, it is essential to improve and facilitate the biological interpretation of complex oxylipin profiles to truly leverage their potential in clinical research. This requires regular updating of our knowledge about the metabolism and the mode of action of oxylipins, and consideration of all factors that may influence circulating oxylipin profiles independently of the studied disease or condition. This review aims to provide the readers with updated and necessary information regarding oxylipin metabolism, their different forms in systemic circulation, the current limitations in deducing oxylipin cellular effects from in vitro bioactivity studies, the biological and technical confounding factors needed to consider for a proper interpretation of oxylipin profiles.
    Trvalý link: https://hdl.handle.net/11104/0354631

     
    Název souboruStaženoVelikostKomentářVerzePřístup
    24_0062_0587350.pdf03.6 MBVydavatelský postprintpovolen
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.